Login / Signup

Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta-analysis.

Tina NhamMichael Cristian GarciaKai La Jennifer TsangJessyca Matos SilvaTyler SchneiderJiawen DengSimran LohitStefan D BaralAnne M Holbrook
Published in: Journal of the American Geriatrics Society (2024)
This systematic review with meta-analysis found donepezil may not be arrhythmogenic. Donepezil was not associated with mortality, ventricular arrhythmias, seizure or syncope, although longer durations of therapy need more study. Further research to clarify actual clinical outcomes related to QTPmed is important to inform prescribing practices.
Keyphrases
  • primary care
  • left ventricular
  • healthcare
  • pulmonary embolism
  • cardiovascular events
  • risk factors
  • stem cells
  • emergency department
  • cardiovascular disease
  • bone marrow
  • mesenchymal stem cells
  • chemotherapy induced